Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study by Petersson, Helena et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Cardiovascular Diabetology
Open Access Original investigation
Sagittal abdominal diameter as a marker of inflammation and 
insulin resistance among immigrant women from the Middle East 
and native Swedish women: a cross-sectional study
Helena Petersson, Achraf Daryani and Ulf Risérus*
Address: Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala, Sweden
Email: Helena Petersson - helena_petersson@hotmail.com; Achraf Daryani - achraf.daryani@pubcare.uu.se; 
Ulf Risérus* - ulf.riserus@pubcare.uu.se
* Corresponding author    
Abstract
Background: Immigrant women from the Middle East have elevated risk of cardiovascular disease.
Sagittal abdominal diameter (SAD), a simple marker of intra-abdominal fat, predicts insulin
resistance and cardiovascular mortality in men. Its usefulness in immigrant women is however
unknown. To investigate the predictive role of SAD compared to other anthropometric measures,
we examined a random sample of native-Swedes and immigrant women from the Middle East living
in Sweden.
Methods: 157 women participated in the study; 107 immigrants and 50 natives. Anthropometric
measurements (SAD, body mass index [BMI], waist circumference [WC] and waist-to-hip ratio
[WHR]; all measured in supine position) and cardiovascular risk factors (C-reactive protein [CRP],
insulin, glucose, insulin resistance [HOMA-IR], blood pressure and serum lipids) were assessed.
The anthropometric measures were compared in their relation to cardiovascular risk factors using
linear regression analyses.
Results: Overall, SAD showed a slightly higher correlation with most cardiovascular risk factors,
especially insulin resistance, insulin, CRP, apolipoprotein B and triglycerides (all P-values < 0.01)
than other anthropometric measures. BMI was however a better predictor of HDL cholesterol.
SAD explained a greater proportion of the variation of insulin resistance and CRP levels, even
independently of the other anthropometric measures.
Conclusion: SAD identifies insulin resistance, subclinical inflammation or raised serum lipids in a
Swedish population with a large proportion of immigrant women from the Middle East. If these
results could be confirmed in a larger population, SAD could be a more clinically useful risk marker
than other anthropometric measures in women at high risk of cardiovascular disease.
Background
To prevent cardiovascular disease, it is important to iden-
tify individuals at particularly high risk. Anthropometric
measures are clinically useful tools since they are non-
invasive and cheap. Anthropometric measures such as
body mass index (BMI) are highly associated with cardio-
vascular disease. Measures of abdominal obesity, e.g.
waist-to-hip ratio [WHR] could be more useful than BMI
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to predict type 2 diabetes [1] and cardiovascular diseases
[2]. Sagittal abdominal diameter (SAD) has recently been
shown to be more strongly associated with metabolic syn-
drome [3,4] and insulin resistance [5,6] compared to
other commonly used anthropometric measures includ-
ing BMI, waist circumference (WC) and WHR. SAD may
also be the best anthropometric marker of cardiovascular
risk factors [5,7,8] and mortality, at least in men [9,10]
(SAD was measured in standing position). The associa-
tion between SAD and C-reactive protein (CRP) is how-
ever limited.
SAD correlates strongly with visceral fat volume as meas-
ured by computed tomography (CT) [11-13], which
might be one explanation for the superior role of SAD in
predicting insulin resistance in men [6]. Indeed, in a small
study including both men and women, the association
between SAD and visceral adipose tissue remained signif-
icant when adjusting for BMI, while the association with
subcutaneous adipose tissue in men did not [11].
There is a need for better, cheaper and non-invasive mark-
ers of cardiovascular risk factors including hypercholeste-
rolemia, hypertension, insulin resistance and elevated
CRP levels. The usefulness of SAD has however mostly
been studied in Caucasian men whereas the knowledge in
other ethnic groups and women is limited. Immigrant
women from the Middle East are a group shown to be at
particularly high risk of cardiovascular disease with high
prevalence of obesity, diabetes and the metabolic syn-
drome [14]. Therefore, it is relevant to find simple mark-
ers that could identify those immigrants at highest risk.
The aim of this study was to compare different anthropo-
metric measures (SAD, BMI, WC and WHR) in a heteroge-
neous group consisting of immigrant women from the
Middle East and native Swedish women with regard to
established cardiovascular and metabolic risk factors,
including insulin resistance and proinflammatory CRP. In
addition, to investigate potential ethnic differences
between anthropometric measures regarding predictive




The study included first-generation immigrant women
born in a Middle Eastern country between the years 1933–
1962, residing in the municipality of Uppsala for at least
3 years. In 1996, 1086 adult women from the Middle East
were living in Uppsala. Eighty percent of those had emi-
grated either from Iran or Turkey. A random sample of 90
women from each of these two counties who fulfilled the
above-mentioned criteria was drawn in collaboration
with SCB (Statistics Sweden). 90 women born in Sweden
were also randomly selected as controls. The women were
contacted through the SCB with a letter describing the
nature of the study and requesting their collaboration.
107 immigrant women (71 from Iran and 36 from Tur-
key) and 50 native Swedes participated.
The study was approved by the Ethical Committee of the
Medical Faculty of Uppsala University. Before entering the
study, all subjects gave informed consent.
A clinical examination was performed at the Obesity Unit,
Uppsala Academic Hospital to assess cardiovascular risk
factors and measure the prevalence of obesity and related
diseases [15]. Participants were instructed to fast for 12 h,
restrain from smoking or snuff, and avoid alcohol and vig-
orous physical activity the day before the examination.
Anthropometric and biochemical measurements
Height was measured to nearest 0.5 cm. Body weight was
measured to the nearest 0.1 kg without shoes in light
indoor clothing. BMI was calculated as the ratio of body
weight (kg) divided by height (m) squared. Waist and hip
circumference was measured in a supine position as
described in the large Swedish Obese Subjects (SOS) study
[16]. WC was measured between the lowest rib and the
iliac crest, and hip circumference was measured at the
widest part of the hip. SAD was measured using a sagit-
tometer (i.e. a sliding beam calliper with a ruler) to the
nearest millimetre. Anteroposterior diameter of the abdo-
men, i.e. "Abdominal height" (cm), was measured in the
sagittal plane during a normal expiration at the level of
iliac crest (L4–5) with the subject in supine position on a
firm bench with the knees bent [6].
Blood pressure (BP) was measured, by indirect ausculta-
tion and with a mercury sphygmomanometer, in the par-
ticipant's right arm after a 5 minutes bed rest. Systolic and
diastolic BP was defined as Korotkoff phases 1 and 5,
respectively.
Blood samples were drawn from an antecubital vein, and
all serum and plasma samples were immediately chilled,
kept on ice, centrifuged, and stored at -70°C until ana-
lyzed. Total cholesterol and triglyceride levels in serum
were assayed by enzymatic techniques by using a Mon-
arch apparatus (Instrumentation Laboratories; Lexington,
Mass.). High density lipoproteins (HDLs) were isolated
by centrifugation and precipitation with magnesium chlo-
ride/phosphotungstate [17]. Low density lipoprotein
(LDL) cholesterol was calculated according to the formula
of Friedewald [18]. Serum apolipoproteins (apo) A-I and
B concentrations were determined by immunoturbidime-
try in a Monarch apparatus. Glucose concentrations were
measured in blood [19] and values were converted to the
corresponding plasma concentrations. Serum insulin was
analyzed using an enzyme immunoassay ELISA-kit (Mer-Cardiovascular Diabetology 2007, 6:10 http://www.cardiab.com/content/6/1/10
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codia AB, Uppsala, Sweden) in a Coda Automated EIA
analyzer (Bio-Rad laboratories AB, Scandinavia). Home-
ostasis model assessment of insulin resistance (HOMA-
IR) was calculated [20]. Plasma high sensitivity CRP was
measured using a rabbit antihuman CRP (Dako A/S, Glos-
trup, Denmark) as capture antibody, rabbit antihuman
CRP (peroxidase conjugated, Dako p0227), human CRP
high control (Dako xo926) as standard, and TMB one sub-
strate (Dako S1600) as substrate.
Statistical Analyses
Normality of variables was tested by the Shapiro-Wilk W
test. SAD, SBP, DBP, insulin, HOMA-IR, triglycerides,
HDL, apoB and CRP were logarithmically transformed
before statistical analysis. Glucose and apoA-I were ana-
lysed by Spearman's rank test. All variables were tested for
linearity by dividing them into quartiles as well as check-
ing the pattern of the residuals. Subjects with CRP levels
>10 mg/l were excluded when performing analyses
including CRP. To investigate the associations between
anthropometric and metabolic variables, Pearson's corre-
lation coefficients were calculated. In addition, regression
coefficients standardised to 1 SD were calculated to be
able to compare the different anthropometric measure-
ments. Relationships between anthropometric and meta-
bolic variables were also examined by multiple linear
regression analysis with three anthropometric measure-
ments (SAD, BMI and WC) as independent variables and
each of the metabolic variables as dependent variable. P <
0.05 was considered as statistically significant. A JMP soft-
ware package was used for statistics (SAS Institute, Cary,
NC). Establishment of linear relationships were made by
visualising plots, residuals and quartile classification.
Results
All relationships analysed were linear. The population
characteristics are presented in Table 1. Four immigrant
and one native subject had a CRP level >10 mg/l.
Univariate analysis in the entire population
For the majority of the cardiovascular risk factors, SAD
was the strongest correlate among the four anthropomet-
ric measures, although the differences between measures
were not profound (Table 2 and Figure 1). For HOMA-IR,
triglycerides, insulin, cholesterol, apoB and CRP, SAD was
however more strongly associated as compared to all the
other anthropometric measures. Concerning prediction of
blood pressure, WC were slightly better than SAD. BMI
were more strongly correlated to HDL cholesterol. WHR
showed in general the weakest correlations. SAD, com-
pared to BMI, WC and WHR, explained a greater portion
of the variation in the insulin resistance and CRP levels
(Figure 1). When excluding one subject with a value of
HOMA-IR more than 8 SDs above the mean (23.5), the
ranking remained similar although the differences
between the anthropometric measures decreased (stand-
ardised regression coefficients: 0.30 [SAD], 0.29 [BMI],
0.25 [WC], 0.19 [WHR]).
Multivariate analysis in the entire population
In multivariate analyses (including SAD, BMI and WC),
SAD was the only measure which remained a significant
predictor of insulin (p = 0.007), HOMA-IR (p = 0.001),
triglycerides (p = 0.009), apoB (p = 0.03) and CRP (p =
0.008). The only measure significantly correlated to systo-
lic and diastolic BP was WC (p = 0.02 and p = 0.005,
respectively) and to HDL was BMI (p = 0.05). When ana-
lysing the immigrant population only, SAD remained as
only predictor of HOMA-IR (p = 0.02) and CRP (p =
0.009) whereas no anthropometric measure was signifi-
cantly related to the other metabolic variables in multivar-
iate analyses.
Sub-analyses
The results were similar when analysing the immigrant
women (Iranian and Turkish) separately (Figure 1). Thus,
SAD performed equally well as in the entire population
also including Swedish women, especially with regard to
prediction of CRP levels, HOMA-IR and cholesterol levels
(Figure 1).
We also performed analyses among the Swedish native
women separately. In line with the results for the entire
group and the immigrant group, SAD performed slightly
better than the other measures. SAD was more strongly
correlated to insulin, HOMA-IR, triglycerides, HDL, LDL/
HDL, apoB and apoB/apoA-I. However, the association
was stronger for WC and WHR concerning blood pressure
and CRP (data not shown in figure).
Dividing by height and adjusting for age
Dividing SAD or WC by height did not change their corre-
lations to the metabolic variables appreciably (data not
shown). When adjusting for age, the correlations gener-
ally weakened but the relations between the anthropo-
metric measures remained.
Discussion
In this study we investigated the association of SAD com-
pared to conventional anthropometric measures, in rela-
tion to cardiovascular and metabolic risk factors among a
heterogeneous population comprised mainly by immi-
grant women from the Middle East, but also Swedish born
women. The analyses were also performed in the immi-
grants only. The data is of clinical relevance since immi-
grant women from the Middle East is a high-risk group of
cardiovascular disease. In general, SAD was a stronger pre-
dictor of cardiovascular risk factors, especially of insulin
resistance, apoB, insulin, triglycerides and CRP, than the
other anthropometric measures. SAD was the only signif-Cardiovascular Diabetology 2007, 6:10 http://www.cardiab.com/content/6/1/10
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icant predictor of insulin resistance and level of serum
CRP after adjustment for BMI and WC. This suggests that
SAD may carry information concerning inflammatory sta-
tus and possibly insulin resistance beyond that of other
measures of obesity and fat distribution. This is in line
with previous studies in men [3,6]. In the current study,
every one-centimetre increase in SAD was associated with
an increase of CRP by 0.41 mg/l, corresponding to an
increased mean CRP level by 16%. This estimation sug-
gests a quite strong association of clinical importance. Ele-
vated levels of serum CRP are associated with the
metabolic syndrome [21,22] and cardiovascular disease
[23,24], and is therefore a relevant risk factor to identify
by non-invasive markers such as SAD. In both men and
women, CRP has been closely related to BMI and WC
[25,26], but the link with SAD has not previously been
investigated.
Secondarily we performed analyses in the Swedish born
population. In this group, the correlations to blood pres-
sure and CRP were stronger for WC and WHR than for
SAD and BMI. This may indicate an ethnic difference
between anthropometric measures regarding the predic-
tive capacity of cardiovascular risk factors. However, since
the sample size of this group was small the results from
those analyses should be interpreted cautiously.
In a Chinese population, the relation between HOMA-IR
and SAD was comparable to WC and BMI but superior to
WHR [27]. In contrast to our study, SAD was measured
with extended legs [27]. It has been shown that SAD meas-
ured with legs bent has higher reliability compared to
measuring SAD with legs straight, resulting in improved
precision [28] and may therefore contribute to the higher
predictive values obtained in the current study. It should
also be noted that not only SAD, but also waist girth and
waist-to-hip ratio was measured in the supine position.
The latter are often measured in standing position which
might increase the measurement error in obese subjects.
SAD might however also reflect visceral fat better than
other anthropometric measures [11-13] which might be
an explanation for the stronger correlation between SAD,
CRP and insulin resistance.
The correlation to the majority of the investigated cardio-
vascular risk factors generally seems to be stronger for SAD
than the other anthropometric variables. Other studies
have obtained a stronger association for SAD to insulin
resistance [6], cardiovascular risk [3] and metabolic syn-
drome [4] than WC, BMI and WHR. In a study by Turcato
et al, SAD and WC were the anthropometric measure-
ments most closely related to cardiovascular risk factors
[7]. In the current study, SAD however showed a similar
correlation as WC for blood pressure, whereas a similar
correlation as BMI with regard to LDL cholesterol. None
of the anthropometric variables were significantly corre-
lated to apoA-I levels. Taken together, our results indicate
that SAD may be a better marker of cardiovascular risk fac-
tors compared to other anthropometric measures. It is
however unclear whether the current differences between
SAD and the other anthropometric indices are clinically
relevant and therefore require further study.
Table 1: Clinical characteristics of the entire population and the immigrant women from the Middle East
Entire population (n = 157) Immigrants (n = 107)
Age (year)* 47 (36–69) 46 (36–69)
SAD (cm)* 21.6 (17.5–30.0) 22.0 (18.0–29.2)
BMI (kg/m2) 26.3 ± 4.3 (18.7–41.2) 27.0 ± 4.5 (18.7–41.2)
WC (cm) 82.4 ± 9.7 (46.0–111.0) 83.4 ± 9.9 (64.0–111.0)
WHR 0.81 ± 0.06 (0.51–0.96) 0.81 ± 0.06 (0.69–0.96)
Systolic BP (mmHg)* 116.0 (92.0–206.0) 112.0 (92.0–180.0)
Diastolic BP (mmHg) 72.3 ± 9.9 (48.0–100.0) 71.7 ± 10.3 (48.0–100.0)
Glucose (mmol/l)* 5.0 (3.7–17.6) 5.0 (4.1–17.6)
HOMA-IR* 1.6 (0.4–23.5) 1.9 (0.5–23.5)
Triglycerides (mmol/l)* 1.1 (0.2–4.2) 1.2 (0.2–4.2)
Cholesterol (mmol/l) 5.3 ± 0.9 (3.2–7.8) 5.2 ± 0.9 (3.2–7.3)
HDL (mmol/l)* 1.4 (0.8–2.7) 1.3 (0.8–2.7)
LDL (mmol/l) 3.3 ± 0.8 (1.4–5.8) 3.2 ± 0.8 (1.4–5.2)
LDL/HDL 2.5 ± 0.9 (1.0–4.9) 2.6 ± 0.9 (1.0–4.9)
ApoB (g/l)* 1.0 (0.5–2.4) 1.0 (0.5–2.4)
ApoA-I (g/l)* 1.5 (1.0–3.5) 1.4 (1.0–3.5)
ApoB/ApoA-I 0.7 ± 0.2 (0.3–1.1) 0.7 ± 0.2 (0.3–1.1)
CRP (mg/l)* 1.8 (0.2–43.9) 2.2 (0.2–43.9)
Data are presented as mean ± SD (minimum value – maximum value). *Not normally distributed variables are described as median (minimum value 
– maximum value). SAD: sagittal abdominal diameter; BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; BP: blood 
pressure; HOMA-IR: homeostasis model assessment of insulin resistance; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein 
cholesterol; Apo: serum apolipoproteins; CRP: C-reactive protein.Cardiovascular Diabetology 2007, 6:10 http://www.cardiab.com/content/6/1/10
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In several studies including this one, WHR showed the
weakest correlation with insulin resistance [3,6,27]. In our
study, WHR overall showed a weaker association with the
cardiovascular risk factors. This trend has also been
observed in some other studies [6,7], which may be
reflected by a lower correlation of WHR with CT-meas-
ured intra-abdominal and subcutaneous fat volumes
compared to SAD, which was the best explanatory varia-
ble for intra-abdominal fat in Mexican-American women
[13]. However, when comparing SAD, WC and WHR in
both men and women, the latter was better in discriminat-
ing ischemic heart disease cases from controls. On the
other hand, when dividing SAD and WC by mid-thigh cir-
cumference, they both become superior to WHR [29].
There are limitations of this study. A larger sample would
have been optimal, but due to the well known low partic-
ipation rate among immigrants in health surveys [14,30]
it is difficult to obtain large samples in immigrants from
the Middle East. We therefore also included native Swedes
despite of a more heterogeneous group. Further, we did
only include Turkish and Iranian women, without any
data in men or women from other Middle Eastern coun-
tries. However, women from these two countries are the
most common among immigrants from Middle East liv-
ing in Sweden. A comparison between these immigrants
and the Swedish born females showed that the immigrant
women were at higher risk for cardiovascular disease [14].
We assessed insulin resistance by HOMA-IR, a surrogate
marker of insulin resistance suggesting the data concern-
ing insulin resistance may need confirmation by more
direct techniques. It should be noted that although
HOMA-IR correlates closely with the clamp method [20],
HOMA-IR mainly reflects hepatic insulin resistance
Comparison of different anthropometric measures with regard to cardiovascular risk factors Figure 1
Comparison of different anthropometric measures with regard to cardiovascular risk factors. Data are presented 
as regression coefficient standardised to 1 SD. A) Entire population (n = 157). B) Immigrants only (n = 107). †P < 0.0001; ‡P < 
0.001; §P < 0.05; NS Not significant. SAD: sagittal abdominal diameter; BMI: body mass index; WC: waist circumference; WHR: 
waist-to-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; HOMA-IR: homeostasis model assessment of 
insulin resistance; TG: triglycerides; Chol: cholesterol; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein 
cholesterol; Apo: apolipoprotein; CRP: C-reactive protein.Cardiovascular Diabetology 2007, 6:10 http://www.cardiab.com/content/6/1/10
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whereas the clamp mainly reflects peripheral insulin
resistance [31].
Conclusion
The results suggest that SAD could be a clinically useful
marker of metabolic risk factors, especially insulin resist-
ance, serum cholesterol levels and low-grade inflamma-
tion in a heterogeneous population including both
immigrant women from the Middle East and native Swed-
ish women. Thus, irrespectively of national origin or ethic
background, SAD is an excellent marker of metabolic and
cardiovascular risk factors. Although the correlation is not
stronger for all risk factors, SAD was the only anthropo-
metric measure that added information beyond that of
BMI, WC and WHR as suggested from the multivariate
analyses. From a practical point of view SAD is virtually
equally simple to measure compared to the other anthro-
pometric measures, suggesting SAD also suitable for clini-
cians. If our results could be confirmed in further studies
with larger sample size and other ethnic groups, SAD
could be a tool to identify immigrants at high cardiovas-
cular and metabolic risk who therefore require lifestyle
and pharmacological intervention.
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